As breakthroughs in cancer treatment continue to accelerate, understanding their impact on healthcare economics is pivotal. In Europe, novel therapies and diagnostics present significant challenges and opportunities for payers and health systems.
Adam Scott, Partner, Mansfield Advisors
Abhishek Patel, Senior Associate, Mansfield Advisors
Henry Elphick, Chair, Mansfield Advisors
Stephane Budel, Co-founder/Partner, DeciBio Consulting
Katie Gillette, Senior Project Manager, DeciBio Consulting
Complete the form below to receive the slides from this webinar.